Clinical Trial Update: TADCLOT- a Double Blind Randomized Controlled Trial [Phase 3]

View source ↗

Summary

A Phase 3, double-blind randomized controlled trial named TADCLOT conducted by the National Institute of Cardiovascular Diseases (Pakistan) has completed, inves…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: National Institute of Cardiovascular Diseases, Pakistan | Conditions: Stent Thrombosis, Myocardial Infarction, Acute | Phase 3 | Status: COMPLETED